New Law Recognizes Family Caregivers
An estimated 65 million family caregivers help their elderly, disabled or ill loved ones continue to live at home – driving them to appointments and assisting with day-to-day needs like bathing, dressing and preparing meals. Few receive recognition, resources or support. But a new law aims to change that.
CAR-T Cancer Drugs Get Nod of Approval from ICER
Innovative but expensive CAR-T therapies for cancer are worth their price, announced the Institute for Clinical and Economic Review recently. The organization is the self-appointed arbiter of drug costs. But its decision was hardly news for those in the cancer community.
Medicaid Rx Coverage Schemes Threaten Patient Access
Cash-strapped states are exploring a controversial new way to cut Medicaid expenses: limiting which drugs their beneficiaries can access.
Medicare Patients Could Gain Access to Critical Diagnostic Test
Nearly 1.7 million Americans learned they had cancer in 2017. Most of these patients began traditional treatments like chemotherapy, radiation and surgery. Yet for many, a groundbreaking new immuno-oncology therapy could have been a better alternative.
Vaccine-preventable Diseases Plague Unprotected Americans
Winter weather blasted much of the nation last week, but it’s not just the common cold that Americans are fighting. Many regions, regardless of temperature, are also being pummeled by a different phenomenon – vaccine-preventable diseases.
Racial Disparity Mars Infants’ Access to Donor Milk
All mothers want to give their babies a stronger immune system, reduce their risk of SIDS and lower their rate of respiratory infections. But a recent study found black babies may be less able to realize these and other benefits of an exclusive human milk diet.
2017 in Review: 7 Trends in Patient Access
As 2017 draws to a close, let’s take a look back at the highlights in patient access this year.
Putting a Price on Migraine Prevention
What are new drugs to prevent migraine worth? The question is driving a forthcoming report from cost-effectiveness giant the Institute for Clinical and Economic Review (ICER) – and already eliciting an outpouring of feedback from the migraine patient community.
A Victory for NICU Patient Safety
Hospital NICUs are getting an early Christmas present: the ability to opt out on tubing that could put their newborn patients at risk.
Revamped EudraVigilance System Could Improve Drug Safety Reporting
Preventable drug safety issues caused nearly 200,000 deaths across the European Union in 2017. Now the European Medicines Agency is working to address that statistic by improving its drug track-and-trace system, known as EudraVigilance.
